Foreign Operations and Sales

12 Months Ended

Dec. 31, 2011

Foreign Operations and Sales [Abstract]

Foreign Operations and Sales

 (17) Foreign Operations and Sales

The following summarized data represents the gross sales and long lived tangible assets for the Company's domestic and foreign entities for 2011, 2010 and 2009:

	Domestic		Foreign		Total
2011
Gross sales	$	83,407	$	171,068	$	254,475
Long-lived assets		34,885		145,735		180,620
2010
Gross sales	$	71,363	$	155,073	$	226,436
Long-lived assets		36,691		156,173		192,864
2009
Gross sales	$	84,518	$	151,759	$	236,277
Long-lived assets		39,227		158,282		197,509

Export sales, included in domestic gross sales, in 2011, 2010 and 2009 amounted to $31,605, $18,529, and $25,768, respectively.

Sales to geographic area consist of the following:

	2011		2010		2009
Europe	$	156,814	$	127,009	$	136,534
North America		75,979		78,497		80,830
Asia		10,448		12,554		10,495
Other		11,234		8,376		8,418
Total	$	254,475	$	226,436	$	236,277

This table summarizes gross sales by product groups:

	2011		2010		2009
APIs and pharmaceutical intermediates	$	229,319	$	203,807	$	212,644
Other		25,156		22,629		23,633
Total	$	254,475	$	226,436	$	236,277

One customer, Gyma, a distributor representing multiple customers, accounted for 10.8%, 12.8% and 11.5% of consolidated gross sales for 2011, 2010 and 2009, respectively.